Items where Author is "Toogeh, G."

(2025) A randomized, two-armed, double-blind, single-dose, cross-over, bioequivalence clinical trial to compare pharmacokinetic parameters and safety of recombinant human factor VIII with Fc fusion produced by AryoGen Pharmed Company versus Elocta® (reference product) in previously treated patients with severe haemophilia A. Annals of Hematology. pp. 1195-1202. ISSN 0939-5555

(2021) Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. Blood Advances. pp. 2987-3001. ISSN 24739529 (ISSN)

(2020) Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study. Journal of Thrombosis and Haemostasis. pp. 2145-2154. ISSN 15387933 (ISSN)

(2018) Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients. Journal of Pharmacopuncture. pp. 76-81. ISSN 2093-6966

(2018) The evaluation of the TGF- beta 1 and T beta RII gene expression in patients with acute lymphoblastic leukemia. World Family Medicine. pp. 198-206. ISSN 1839-0188

(2016) A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor. Clinical and Applied Thrombosis-Hemostasis. pp. 184-190. ISSN 1076-0296

(2015) A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency. Clinical and Applied Thrombosis-Hemostasis. pp. 724-728. ISSN 1076-0296